Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla Weetall

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Pharmacology Research & Perspectives|March 21, 2020
In vitro metabolism, reaction phenotyping, enzyme kinetics, CYP inhibition and induction potential of atalurenRonald Kong, Jiyuan Ma, Seongwoo Hwang, et al.
Plos One|September 18, 2024
Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson's diseaseAngela Minnella, Kevin P McCusker, Akiko Amagata, et al.
Plos One|June 29, 2017
Identification of benzazole compounds that induce HIV-1 transcriptionJason D Graci, Daniel Michaels, Guangming Chen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 30, 2021
In vitro metabolism, pharmacokinetics and drug interaction potentials of emvododstat, a DHODH inhibitorJiyuan Ma, Diksha Kaushik, Shirley Yeh, et al.
Experimental Hematology|April 26, 2019
Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1Karina Barbosa, Anagha Deshpande, Bo-Rui Chen, et al.
Pharmacology Research & Perspectives|December 7, 2018
Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organsAgnès Poirier, Marla Weetall, Katja Heinig, et al.
Oncotarget|July 10, 2018
Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphomaAya Maeda, Yuki Nishida, Marla Weetall, et al.
Molecular Cancer Therapeutics|July 21, 2018
Inhibition of BMI1, a Therapeutic Approach in Endometrial CancerMegan Buechel, Anindya Dey, Shailendra Kumar Dhar Dwivedi, et al.
European Journal of Medicinal Chemistry|October 15, 2022
SAR studies toward discovery of emvododstat (PTC299), a potent dihydroorotate dehydrogenase (DHODH) inhibitorRamil Y Baiazitov, Hongyan Qi, Tamil Arasu, et al.
Clinical Pharmacology in Drug Development|June 17, 2016
Phase 1 Study of Safety, Tolerability, and Pharmacokinetics of PTC299, an Inhibitor of Stress-Regulated Protein TranslationMarla Weetall, Thomas Davis, Gary Elfring, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Pharmacology Research & Perspectives|March 21, 2020
In vitro metabolism, reaction phenotyping, enzyme kinetics, CYP inhibition and induction potential of atalurenRonald Kong, Jiyuan Ma, Seongwoo Hwang, et al.
Plos One|September 18, 2024
Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson's diseaseAngela Minnella, Kevin P McCusker, Akiko Amagata, et al.
Plos One|June 29, 2017
Identification of benzazole compounds that induce HIV-1 transcriptionJason D Graci, Daniel Michaels, Guangming Chen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 30, 2021
In vitro metabolism, pharmacokinetics and drug interaction potentials of emvododstat, a DHODH inhibitorJiyuan Ma, Diksha Kaushik, Shirley Yeh, et al.
Experimental Hematology|April 26, 2019
Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1Karina Barbosa, Anagha Deshpande, Bo-Rui Chen, et al.
Pharmacology Research & Perspectives|December 7, 2018
Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organsAgnès Poirier, Marla Weetall, Katja Heinig, et al.
Oncotarget|July 10, 2018
Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphomaAya Maeda, Yuki Nishida, Marla Weetall, et al.
Molecular Cancer Therapeutics|July 21, 2018
Inhibition of BMI1, a Therapeutic Approach in Endometrial CancerMegan Buechel, Anindya Dey, Shailendra Kumar Dhar Dwivedi, et al.
European Journal of Medicinal Chemistry|October 15, 2022
SAR studies toward discovery of emvododstat (PTC299), a potent dihydroorotate dehydrogenase (DHODH) inhibitorRamil Y Baiazitov, Hongyan Qi, Tamil Arasu, et al.
Clinical Pharmacology in Drug Development|June 17, 2016
Phase 1 Study of Safety, Tolerability, and Pharmacokinetics of PTC299, an Inhibitor of Stress-Regulated Protein TranslationMarla Weetall, Thomas Davis, Gary Elfring, et al.
Pageof 7